Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.2 BRL | +1.46% | +2.03% | +10.15% |
08/06 | US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59 | RE |
07/06 | Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds | RE |
Evolution of the average Target Price on Pfizer Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Pfizer Inc.
DA Davidson | |
Redburn Atlantic | |
Morgan Stanley | |
Leerink Partners | |
BMO Capital | |
DZ BANK | Elmar Kraus |
JPMORGAN | Chris Schott |
UBS | Trung Huynh |
JEFFERIES | Akash Tewari |
BERENBERG | Kerry Holford |
Argus | |
Guggenheim | |
TD Cowen | |
JPMorgan Chase | |
Redburn | |
Wells Fargo Securities | |
Daiwa Securities | |
Truist Securities | |
Cantor Fitzgerald | |
Barclays | |
Jefferies & Co. | |
Goldman Sachs | |
Credit Suisse | |
SVB Securities LLC | |
HSBC | |
Berenberg Bank | |
BofA Securities | |
Atlantic Equities | |
Citigroup | |
Mizuho Securities | |
Atlantic Securities | |
SVB Leerink | |
Independent Research | |
RBC | |
RBC Capital Markets | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- PFE Stock
- PFIZ34 Stock
- Consensus Pfizer Inc.